臺灣博碩士論文加值系統

C型肝炎病毒 (Hepatitis C Virus，HCV) 為一單股正向RNA病毒。先前的研究已知病毒非結構性蛋白質NS3具有serine protease與helicase的生物活性，而其serine protease的活化需要非結構性蛋白質NS4A作為輔因子。NS4A會與NS3結合形成穩定的複合物，增進NS3 serine protease的切割作用，對於HCV非結構性蛋白質的成熟扮演重要的角色。近幾年的研究指出，NS4A會廣泛地抑制細胞與病毒的轉譯作用。本實驗室先前利用GST pull down的方法發現NS4A可藉中間區域與細胞內轉譯延伸因子eEF1A結合。本研究中，利用螢光酵素 (luciferase) 為報導質體，分別進行活體外轉錄轉譯反應及細胞轉染，證明NS4A抑制轉譯的作用是存在的，並更進一步定出eEF1A是利用羧基端與NS4A產生交互作用。另外，對NS4A進行胺基酸的點突變，以免疫沉澱法與西方點墨法分析，發現NS4A(V23A) 和NS4A(I25AV26A) 與eEF1A結合能力較NS4A野生株為弱，另外利用luciferase assay也觀察到NS4A(V23A) 與NS4A(I25AV26A) 對於抑制luciferase蛋白質的合成效果較野生株差；反之，NS4A(V24A) 與eEF1A的結合能力則與NS4A野生株相當，在抑制luciferase活性上的程度亦與NS4A野生株相當。eEF1A是轉譯進行的重要因子，依上述結果可推測，NS4A可能藉由與eEF1A的結合來影響轉譯的進行。
另一方面，先前Yang等人的研究顯示，在一些哺乳動物的細胞中 （HepG2、COS-7和NIH3T3），輔因子NS4A存在時會活化NS3 serine protease，繼而促使NS3被截切為更小的片段，稱之為NS3的內切片段。在本研究中，對於NS3內切反應的作用機制也作了探討，結果顯示即使是保有作為NS3 serine protease輔因子活性的NS4A變異株 [NS4A(I25AV26A)]，也不足以使NS3產生內切片段。這顯示內切片段的產生可能不是NS3具有serine protease的活性即可達成的，這點與Yang等人觀點不相同。此一研究亦顯示NS4A第25個位置之Isoleucine及/或第26個位置之Valine，對於NS3能否被內切具有關鍵性的角色。此外，Yang等人研究指出NS3的內切片段較完整的NS3具有更高的轉型能力，於是本研究利用soft agar assay比較NS4A或NS4A(I25AV26A) 存在時對於NS3轉型能力的影響。結果顯示，相較於其他實驗組，NS4A與NS3存在下，細胞轉型的比例最高。但由於長出的聚落太少，誤差值較大，且其中轉染v-Src的正控制組其細胞轉型的聚落數偏低，因此有關於NS4A對NS3轉型能力的影響仍需作進一步的確認。了解HCV各個蛋白質之間的相互作用，相信對於HCV致病機制上能有更深一層的了解。

Hepatitis C virus (HCV) is a positive, single-stranded RNA virus. Previous studies have demonstrated that the viral nonstructural protein NS4A interacts with NS3 and is a cofactor of NS3 serine protease essential for the proteolytic processing of the viral polyprotein. NS4A protein was also demonstrated to inhibit cellular and viral protein synthesis. By performing GST pull down assay, our laboratory has previously identified eEF1A that specifically interacted with NS4A. The purpose of this study was to examine whether NS4A inhibits protein translation via interacting with eEF1A. By performing luciferase assay, the inhibition of translation by NS4A protein was confirmed in this study. The eEF1A C-terminal domain, responsible for binding with eEF1B and tRNA was identified to be involved in the interaction. Furthermore, mutations at Val-23 [NS4A(V23A)] and at Ile-25 and Val-26 [NS4A(I25AV26A)] disrupted the interaction between NS4A and eEF1A. The effect of NS4A on translation inhibition was also decreased with V23 and I25AV26A mutations. In contrast, a mutation at Val-24 [NS4A(V24A)] remained the ability of NS4A to interact with eEF1A and the inhibition effect on luciferase activity. These results suggest NS4A may interfere with protein synthesis by forming complex with eEF1A. This may be involved in HCV infection and helps its survival in host cells.
It was reported the NS3 protein is internally cleaved in the presence of NS4A when expressed in HepG2, COS-7, and NIH3T3 cells. The internal cleavage of NS3 protein required not only NS4A as a cofactor but also the activity of NS3 serine protease. However, in this study, we found that NS4A(I25AV26A) that retains the function to act as a cofactor of NS3 was unable to induce the internal cleavage of NS3. It suggests that the serine protease activity of NS3 is not sufficient for its internal cleavage. In addition, the internal cleavage products of NS3 appeared to have higher oncogenic potential than the intact NS3. In this study, soft agar analysis was performed to compare the transformation activity of NS3 in the presence of NS4A or NS4A(I25AV26A). Preliminary data did indicate a higher transformation activity of NS3 in the presence of wild type NS4A. Nevertheless, the numbers of transforming colonies were low and may need to be further confirmed. The possible roles of the interactions among the viral nonstructural proteins, on the oncogenesis of HCV infection remain to be elucidated.

目錄
目錄………………………………………………………1
圖表目錄…………………………………………………2
中文摘要…………………………………………………3
英文摘要…………………………………………………4
緒論………………………………………………………5
研究方向………………………………………………..10
材料方法………………………………………………..12
結果……………………………………………………..28
討論……………………………………………………..36
圖表……………………………………………………..42
參考文獻………………………………………………..56

Bartenschlager RL, Ahlborn-Laake L, Yasargil K, Mous J, Jacobsen H. 1995. Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol 69:198-205.
Blackwell JL, Brinton MA. 1997. Translation elongation factor-1 alpha interacts with the 3'' stem-loop region of West Nile virus genomic RNA. J Virol 71:6433-44.
Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, and Maynard JE. 1985. Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology 88:773-9.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, and Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-62.
Cimarelli A, and Luban J. 1999. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol 73:5388-401.
Condeelis J. 1995. Elongation factor 1 alpha, translation and the cytoskeleton. Trends Biochem Sci 20:169-70.
Darke PL, Jacobs AR, Waxman L, Kuo LC. 1999. Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing. J Biol Chem 274:34511-4.
Das T, Mathur M, Gupta AK, Janssen GM, and Banerjee AK. 1998. RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A 95:1449-54.
De Nova-Ocampo M, Villegas-Sepúlveda N, del Angel RM. 2002. Translation elongation factor-1 , La, and PTB Interact with the 3'' untranslated region of Dengue 4 Virus RNA. Virology 295:337-47.
Failla C, Tomei L, De Francesco R. 1994. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 68:3753-60.
Falgout B, Pethel M, Zhang YM, Lai CJ. 1991. Both nonstructural proteins NS2B and NS3 are required for proteolytic processing of Dengue virus nonstructural proteins. J Virol 65:2467-75.
Feitelson MA, Zhu M, Duan LX, London WT. 1993. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-17.
Florese RH, Nagano-Fujii M, Iwanaga Y, Hidajat R, Hotta H. 2002. Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus. Virus Res 90:119-31.
Fujita T, Ishido S, Muramatsu S, Itoh M, Hotta H. 1996. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun. 229:825-31.
Gale MJ, Kwieciszewski B, Dossett M, Nakao H, Katze MG. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 73:6506-16.
Gingras AC, Svitkin Y, Belsham GJ, Pause A, Sonenberg N. 1996. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc Natl Acad Sci USA 93:5578-83.
Gonen H, Smith CE, Siegel NR, Kahana C, Merrick WC, Chakraburtty K, Schwartz AL, and Ciechanover A. 1994. Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci U S A 91:7648-52.
Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. 1993. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A 90:10583-7.
Haghighat A, Svitkin Y, Novoa l, Kuechler E, Skern T, Sonenberg N. 1996. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol 70:8444-50.
Harris KS, Xiang W, Alexander L, Lane WS, Paul AV, Wimmer E. 1994. Interaction of poliovirus polypeptide 3CDpro with the 5'' and 3'' termini of the poliovirus genome: identification of viral and cellular cofactors needed for efficient binding. J Biol Chem 269: 27004-14.
Hirota M, Satoh S, Asabe S, Kohara M, Tsukiyama-Kohara K, Kato N, Hijikata M, Shimotohno K. 1999. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation.
Virology 257:130-7.
Ishido S, Hotta H. 1998. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett 438:258-262.
Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M. 2002. Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo. J Med Virol 66:187-99.
Keng FT, Wright JP. 1997. Internal proteolysis of the NS3 protein specified by Dengue virus 2. J Gen Virol 78:337-41.
Kim DW, Gwack Y, Han JH, Choe J. 1997. Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein. Virus Res 49:17-25.
Koch JO, Lohmann V, Herian U, Bartenschlager R. 1996. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. Virology 221:54-66.
Kolykhalov AA, Agapov EV, Rice CM. 1994. Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. J Virol 68:7525-33.
Komoda Y, Hijikata M, Sato S, Asabe SI, Kimura K, Shimotono K. 1994. Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in E. coli. J Virol 68: 7351-7.
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-4.
Kwong AD, Kim JL, Rao G, Lipovsek D, Raybuck SA. 1998. Hepatitis C virus NS3/4A protease. Antiviral Res 20:1-18.
Lane DP, Crawford LV. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-3.
Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102:2292-7.
Liebig H-D, Ziegler E, Yan R, Hartmuth K, Klump H, Kowalski H, Blaas D, Sommergruber W, Frasel L, Rhoads RE, Kuechler E, Skern T. 1993. Purification of two picronaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. Biochemistry 32:7581-8.
Lin C, Thomson JA, Rice CM. 1995. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 69:4373-80.
Majumder M, Ghosh AK, Steele R, Ray R, and Ray RB. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75:1401-7.
Munshi R, Kandl KA, Carr-Schmid A, Whitacre JL, Adams AE, Kinzy TG. 2001. Overexpression of translation elongation factor 1A affects the organization and function of the actin cytoskeleton in yeast. Genetics 157:1425-36.
Muramatsu S., Ishido S, Fujita T, Itoh M, Hotta H. 1997. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71:4954-61.
Murray JW, Edmonds BT, Liu G, and Condeelis J. 1996. Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends. J Cell Biol 135:1309-21.
Neddermann P, Clementi A, De FR. 1999. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol 73:9984-91.
Pang PS, Jankowsky E, Planet PJ, Pyle AM. 2002. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J 21:1168-76.
Park JS, Yang JM, Min MK. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. 2000. Biochem Biophys Res Commun 267:581-7.
Sakamuro D, Furukawa T, Takegami T. 1995. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol 69:3893-6.
Santolini E, Migliaccio G, La Monica N. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68:3631-41.
Satoh S, Tanji Y, Hijikata M, Kimura K, Shimotohno K. 1995. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol 69:4255-60.
Shiina N, Gotoh Y, Kubomura N, Iwamatsu A, and Nishida E. 1994. Microtubule severing by elongation factor 1 alpha. Science 266:282-5.
Shimoike T, Mimori S, Tani H, Matsuura Y, Miyamura T. 1999. Interaction of hepatits C virus core protein with viral sense RNA and suppression of its translation. J Virol 73:9718-25.
Steinkuhler C, Urbani A, Tomei L, Biasiol MS, Bianchi E, Pessi A, De Francesco R. 1996. Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol 70:6694-700.
Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-13.
Tanji Y, Hijikata M, Satoh S, Kaneko T, Shimotohno K. 1995a. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 69:1575-81.
Tanji, Y., Kaneko, T., Satoh, S., and Shimotohno, K. 1995b. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69:3980-6.
Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, et al. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-8.
White E. 1995. Regulation of p53-dependent apoptosis by E1A and E1B. Curr Top Microbiol Immunol 199:33-58
Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D. 2000. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 74:2293-304.
Yang F, Demma M, Warren V, Dharmawardhane S, and Condeelis J. 1990. Identification of an actin-binding protein from Dictyostelium as elongation factor 1a. Nature 347:494-6.
Yang SH, Lee CG, Song MK, Sung YC. 2000. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease. Virology 268:132-40.
Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y, Golan-Goldhirsh A, Kunin M, Berdichevsky Y, Benhar I, Tur-Kaspa R. 2001. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat 8:96-102.